SCHEMBL21756932

SCHEMBL21756932

CC(C)c1c(F)cc(I)cc1CN(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
POLB P06746 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
THRB P10828 1/20 0.38
G6PD P11413 1/20 0.38
PABPC1 P11940 1/20 0.38
KMT2A Q03164 1/20 0.38
HKDC1 Q2TB90 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
SLC6A4 P31645 11/20 0.34
SLC6A2 P23975 8/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
ALOX15 P16050 2/20 0.33
GSR P00390 1/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21756927 0.79 GABRA1 (0.31)
SCHEMBL21756926 0.79 GABRA1 (0.35)
SCHEMBL21756924 0.77 GABRA1 (0.41)
SCHEMBL21765274 0.77 KDM4E (0.42) ALDH1A1KDM4EMEN1POLBGAA
SCHEMBL21756925 0.76 PRKCE (0.33) ALDH1A1MEN1MAPTKMT2ATDP1
SCHEMBL21756947 0.76 SLC6A4 (0.32) SLC6A4SLC6A2HTR2A
SCHEMBL21765279 0.73 GABRA1 (0.32)
SCHEMBL21765276 0.70 GABRA1 (0.35)
SCHEMBL21756930 0.70 GABRA1 (0.35)
SCHEMBL21756923 0.69 SLC6A4 (0.46) ALDH1A1KDM4EMEN1POLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020039088-A2 NOVEL COMPOUNDS Xeniopro GmbH (DE) 2020-02-27 WO disclosed
WO-2020039092-A2 NOVEL AROMATIC MOLECULES Xeniopro GmbH (DE) 2020-02-27 WO disclosed
US-9403829-B2 Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1H)-one, a solid form thereof and methods of their use SIGNAL PHARMACEUTICALS, LLC (US) 2016-08-02 US disclosed